menu search

PLXP / PLx Pharma (PLXP) Q3 2022 Earnings Call Transcript

PLx Pharma (PLXP) Q3 2022 Earnings Call Transcript
PLx Pharma Inc. (NASDAQ:PLXP ) Q3 2022 Earnings Conference Call November 11, 2022 8:30 AM ET Company Participants Natasha Giordano - President, Chief Executive Officer Rita O'Connor - Chief Financial Officer Asif Ali - Preventative Cardiologist Janet Barth - Vice President, Investor Relations Conference Call Participants Leland Gershell - Oppenheimer Jason Butler - JMP Securities Operator Ladies and gentlemen, thank you for standing by and welcome to PLx Pharma's third quarter 2022 earnings conference call. At this time, all participants are in a listen-only mode. Read More
Posted: Nov 11 2022, 11:13
Author Name: Seeking Alpha
Views: 102629

PLXP News  

Why Is PLx Pharma (PLXP) Stock Down 32% Today?

By InvestorPlace
April 12, 2023

Why Is PLx Pharma (PLXP) Stock Down 32% Today?

PLx Pharma (NASDAQ: PLXP ) stock continues to fall on Wednesday as the company gets closer to being delisted from the Nasdaq Exchange . An update from more_horizontal

Why Is PLx Pharma (PLXP) Stock Down 38% Today?

By InvestorPlace
April 11, 2023

Why Is PLx Pharma (PLXP) Stock Down 38% Today?

PLx Pharma (NASDAQ: PLXP ) stock is taking a beating on Tuesday and there's a couple of reasons investors will want to know about its fall. First off, more_horizontal

PLx Pharma (PLXP) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 11, 2022

PLx Pharma (PLXP) Q3 2022 Earnings Call Transcript

PLx Pharma Inc. (NASDAQ:PLXP ) Q3 2022 Earnings Conference Call November 11, 2022 8:30 AM ET Company Participants Natasha Giordano - President, Chief more_horizontal

PLx Pharma, Inc. (PLXP) Reports Q1 Loss, Lags Revenue Estimates

By Zacks Investment Research
May 13, 2022

PLx Pharma, Inc. (PLXP) Reports Q1 Loss, Lags Revenue Estimates

PLx Pharma, Inc. (PLXP) delivered earnings and revenue surprises of 4.35% and 11.36%, respectively, for the quarter ended March 2022. Do the numbers h more_horizontal

PLx Pharma Inc. to Discuss 2022 First Quarter Financial Results on May 13, 2022 Conference Call and Provide Business Update

By GlobeNewsWire
April 22, 2022

PLx Pharma Inc. to Discuss 2022 First Quarter Financial Results on May 13, 2022 Conference Call and Provide Business Update

SPARTA, N.J., April 22, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery more_horizontal

PLx Pharma Inc. (PLXP) CEO Natasha Giordano on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 11, 2022

PLx Pharma Inc. (PLXP) CEO Natasha Giordano on Q4 2021 Results - Earnings Call Transcript

PLx Pharma Inc. (PLXP) CEO Natasha Giordano on Q4 2021 Results - Earnings Call Transcript more_horizontal

Dipexium Pharmaceuticals, Inc. (PLXP) Reports Q4 Loss, Misses Revenue Estimates

By Zacks Investment Research
March 11, 2022

Dipexium Pharmaceuticals, Inc. (PLXP) Reports Q4 Loss, Misses Revenue Estimates

Dipexium Pharmaceuticals, Inc. (PLXP) delivered earnings and revenue surprises of -5.80% and 17.51%, respectively, for the quarter ended December 2021 more_horizontal

PLx Pharma Inc. to Present at Oppenheimer & Co's 32nd Annual Healthcare Conference on March 15, 2022

By GlobeNewsWire
March 1, 2022

PLx Pharma Inc. to Present at Oppenheimer & Co's 32nd Annual Healthcare Conference on March 15, 2022

SPARTA, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery more_horizontal


Search within

Pages Search Results: